第5版WHO造血与淋巴组织肿瘤分类B细胞肿瘤分类解读  

Introduction on the update of the 5th edition WHO classifications of B-cell neoplasms

作　　者：饶慧兰[1] 王哲 Rao Huilan;Wang Zhe(Department of Pathology,Sun Yat-sen University Cancer Center,Guangzhou 510060,China;Department of Pathology,School of Basic Medicine,Fourth Military Medical University,Xi′an 710032,China)

机构地区：[1]中山大学肿瘤防治中心病理科,广州510060 [2]空军军医大学病理学教研室,西安710032

出　　处：《中华病理学杂志》2024年第1期6-11,共6页Chinese Journal of Pathology

摘　　要：第5版WHO造血与淋巴组织肿瘤分类中的B细胞肿瘤分类更新包括更新分类名称、强化诊断标准以及从临时分类升级为确定类型。本文主要关注B细胞肿瘤各章节内容重要进展和变化,方便国内从事造血与淋巴组织肿瘤诊治的医师了解最新进展,指导日常工作。The 5th edition WHO classification of B-cell tumors is a systematic update to the fourth revised version of the classification.The changes include updated names of entities,sharpened diagnostic criteria,and upgrades from provisional to definite entities.This review focuses on the changes in the content of each chapter of B-cell tumors,facilitating domestic colleagues engaged in the diagnosis and treatment of lymphohematopoietic tumors to understand the latest progress and guide daily work.

关 键 词：血液和淋巴系统疾病 分子生物学 淋巴瘤 B细胞 

分 类 号：R733.1[医药卫生—肿瘤]